CHD Strangle Strategy
CHD (Church & Dwight Co., Inc.), in the Consumer Defensive sector, (Household & Personal Products industry), listed on NYSE.
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors.
CHD (Church & Dwight Co., Inc.) trades in the Consumer Defensive sector, specifically Household & Personal Products, with a market capitalization of approximately $22.53B, a trailing P/E of 30.68, a beta of 0.48 versus the broader market, a 52-week range of 81.33-106.04, average daily share volume of 2.0M, a public-listing history dating back to 1980, approximately 6K full-time employees. These structural characteristics shape how CHD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.48 indicates CHD has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. CHD pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on CHD?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current CHD snapshot
As of May 15, 2026, spot at $94.56, ATM IV 21.90%, IV rank 3.00%, expected move 6.28%. The strangle on CHD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 98-day expiry.
Why this strangle structure on CHD specifically: CHD IV at 21.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a CHD strangle, with a market-implied 1-standard-deviation move of approximately 6.28% (roughly $5.94 on the underlying). The 98-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CHD expiries trade a higher absolute premium for lower per-day decay. Position sizing on CHD should anchor to the underlying notional of $94.56 per share and to the trader's directional view on CHD stock.
CHD strangle setup
The CHD strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CHD near $94.56, the first option leg uses a $100.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CHD chain at a 98-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CHD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $100.00 | $2.33 |
| Buy 1 | Put | $90.00 | $2.60 |
CHD strangle risk and reward
- Net Premium / Debit
- -$492.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$492.50
- Breakeven(s)
- $85.08, $104.93
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
CHD strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on CHD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$8,506.50 |
| $20.92 | -77.9% | +$6,415.84 |
| $41.82 | -55.8% | +$4,325.17 |
| $62.73 | -33.7% | +$2,234.51 |
| $83.64 | -11.6% | +$143.85 |
| $104.54 | +10.6% | -$38.18 |
| $125.45 | +32.7% | +$2,052.48 |
| $146.36 | +54.8% | +$4,143.14 |
| $167.26 | +76.9% | +$6,233.81 |
| $188.17 | +99.0% | +$8,324.47 |
When traders use strangle on CHD
Strangles on CHD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CHD chain.
CHD thesis for this strangle
The market-implied 1-standard-deviation range for CHD extends from approximately $88.62 on the downside to $100.50 on the upside. A CHD long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CHD IV rank near 3.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CHD at 21.90%. As a Consumer Defensive name, CHD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CHD-specific events.
CHD strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CHD positions also carry Consumer Defensive sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CHD alongside the broader basket even when CHD-specific fundamentals are unchanged. Always rebuild the position from current CHD chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on CHD?
- A strangle on CHD is the strangle strategy applied to CHD (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CHD stock trading near $94.56, the strikes shown on this page are snapped to the nearest listed CHD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CHD strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CHD strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 21.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$492.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CHD strangle?
- The breakeven for the CHD strangle priced on this page is roughly $85.08 and $104.93 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CHD market-implied 1-standard-deviation expected move is approximately 6.28%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on CHD?
- Strangles on CHD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CHD chain.
- How does current CHD implied volatility affect this strangle?
- CHD ATM IV is at 21.90% with IV rank near 3.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.